Therapeutic Inertia

Introducing the OTI Initiative

Despite the approval of more than 40 new diabetes treatment options since 2005, as well as advancements in guidelines and treatment algorithms, we still haven’t been able to make a meaningful difference in improving glycemic control in people with type 2 diabetes. In fact, between 1999 and 2014 the percentage of patients with diabetes with an A1C over 9% actually increased. This phenomenon is known as therapeutic inertia—delay or inaction to initiate or intensify therapy when glycemic treatment goals have not been met.

Through the Overcoming Therapeutic Inertia

Through the Overcoming Therapeutic Inertia (OTI) initiative, the American Diabetes Association® (ADA) is doing its part in creating a paradigm shift in the care of type 2 diabetes, advancing the latest thought-leadership in the category and developing purposeful practice resources and tools.

We are working across the entire health continuum to help physicians, nurse practitioners, physician assistants, pharmacists, dietitians, and diabetes educators more effectively partner with their patients to implement the most effective care strategies for proper glycemic control.

Clinical Self-Assessment Tools

Therapeutic Inertia in Clinical Practice: Self-Assessment

Therapeutic Inertia in Clinical Practice: Self-Assessment

Use this tool to measure how often therapeutic inertia occurs in your practice and to identify contributing factors. This tool can also be used to help detect therapeutic inertia between visits.

Take the Survey
Clinical Self-Assessment Tool

Clinical Self-Assessment Tool

Helping people living with diabetes get access to timely, effective care is a goal all care providers have. Take our assessment test and learn how be an inertia buster and give patients an optimal health care experience.

Download Now

ADA’s Overcoming Therapeutic Inertia initiative is supported by:


Novo Nordisk Logo Sanofi